Statistics
The NRx Pharmaceuticals stock price is currently $ 2.19 with a total market cap valuation of $ 94.82M (43.30M shares outstanding). The NRx Pharmaceuticals is trading on NASDAQ under the ticker sign NRXP. NRx Pharmaceuticals price is up
Description
NRx Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development of novel therapies for central nervous system ailments and life-threatening lung conditions. Its portfolio includes ZYESAMI, an investigational medicine that has progressed through Phase IIb/III clinical trials for severe respiratory distress linked to COVID-19. Additionally, the company is advancing NRX-100 and NRX-101, orally administered treatments engineered to address bipolar depression in individuals exhibiting both acute and sub-acute suicidal ideation and actions. This Delaware-based company, located in Wilmington, was established in 2015.
Company Profile
- Full Name: NRx Pharmaceuticals
- Sector: Healthcare
- Website: https://www.nrxpharma.com
